What Is Neolipyl? How This New Lipid-Repairing Active Ingredient Works for Dry Skin (2026)
Summary
Neolipyl is a 100% natural-origin cornflower extract by Silab that repairs the lipid matrix of dry skin, with niacinamide-comparable hydration results within 14 days at 0.5 to 2% concentration. It also reduces the dryness and irritation associated with retinol without compromising retinol's anti-wrinkle performance.
Detailed Answer
Reviewed for accuracy by the Skin and Hair Insights editorial team. All claims are cross-referenced against trade press, manufacturer-published clinical data, and publicly available regulatory information. Last reviewed: May 2026. This article is educational and does not endorse any specific commercial product.
Neolipyl is a patented natural active ingredient developed by French cosmetic biotechnology company Silab, launched in 2025, with the INCI name Water and Centaurea Cyanus Flower Extract. It is engineered to re-equilibrate the lipid matrix of dry or irritated skin by acting on both the composition and structure of the skin's barrier lipids, producing visible hydration and smoothing effects within 14 days of twice-daily application.
Before getting into the science, here is a quick-reference comparison of Neolipyl against two well-established actives it has been tested alongside:
| Attribute | Neolipyl | Niacinamide | Retinol |
|---|---|---|---|
| Primary mechanism | Lipid matrix restructuring (composition and organization) | Barrier support, sebum regulation, brightening | Collagen stimulation, cell turnover acceleration |
| Natural origin content | 100% (ISO 16128) | Synthetic vitamin B3 | Synthetic or nature-identical vitamin A |
| Onset of visible results | 14 days (twice-daily) | Around 4 weeks (typical) | 4 to 12 weeks (typical) |
| Recommended dose in formula | 0.5 to 2% | 2 to 10% | 0.025 to 1% |
| Key skin concern addressed | Dry or barrier-compromised skin | Uneven tone, enlarged pores, mild barrier support | Wrinkles, texture, photoaging |
| Retinol compatibility | Complementary: limits retinol side effects | Debated in some formulation contexts | N/A |
| Award recognition (2026) | PCHi Fountain Awards (2nd prize, Skin Barrier Repair) and ICIC Award | N/A | N/A |
| Regulatory compliance | EU, USA, China, Japan | Global | Varies by concentration and region |
Sources: Premium Beauty News, Euro Cosmetics, in-Cosmetics Asia product listing.
What exactly is Neolipyl and where does it come from?
Neolipyl is a repairing natural active ingredient derived from the flowering tops of cornflower (Centaurea cyanus), a plant sourced from French suppliers certified for organic agriculture. The raw material is processed using a natural enzyme engineering technique to isolate a proline-rich peptide fraction, which is the bioactive component responsible for its lipid-repairing properties.
The INCI declaration is simple: Water and Centaurea Cyanus Flower Extract. That simplicity sits on top of a more involved development process. Silab applied its expertise in lipidomics and optical biopsies to first characterize what goes wrong in dry skin at the molecular level, and then designed an ingredient to address it at that level.
Cornflower has a long history in European cosmetics as a soothing, anti-inflammatory botanical, appearing most often in eye-care products and toners. Silab's contribution is going beyond surface-level calming: by isolating the proline-rich peptide fraction and validating its activity against a specific lipid-disorder pattern, the company has repositioned cornflower as a precision lipid-repair tool rather than a general calming agent.
Neolipyl complies with biodiversity regulations, carries 100% natural origin content per ISO 16128, and meets cosmetics regulations across Europe, the USA, China, and Japan. It is available as an aqueous solution, which Silab notes makes it easy to incorporate into a wide range of formulations.
What is the lipid matrix of dry skin, and why does it matter?
To understand what Neolipyl does, it helps to understand what it is correcting. The skin barrier, specifically the stratum corneum, is a layered structure in which flattened dead skin cells called corneocytes sit inside a lipid matrix made up primarily of ceramides, free fatty acids, and cholesterol. This architecture controls how much water the skin loses and how well it keeps irritants out.
Dry or irritated skin is not simply skin that lacks surface moisture. Silab's lipidomic research identified a specific lipid signature of dry skin: a state in which both the types and ratios of lipids present (composition) and how those lipids are organized into lamellar layers (structure) are disrupted. When the lipid matrix is disordered, the barrier loses water faster than it should and becomes vulnerable to irritants, which feeds a cycle of continued dryness and sensitivity.
At the ICIC Award ceremony in Shanghai, Silab CEO Brigitte Closs-Gonthier described the significance of this work: "By leveraging our dual expertise in lipidomics and optical biopsies, we managed to establish the lipid signature of dry skin for the first time. Based on these studies, we were able to determine the global repairing properties of our active ingredient on Caucasian and Asian volunteers with dry skin."
This distinction matters when comparing Neolipyl to other moisturizing approaches. Humectants like hyaluronic acid attract water; occlusives like petrolatum seal it in; emollients smooth the surface. Neolipyl targets the upstream problem, the disordered lipid matrix itself, by restoring the synthesis of epidermal lipids that are impaired in dry skin and by improving their conformation and organization.
For a broader grounding in how the skin barrier works structurally, see our technical guide to the skin barrier.
How does Neolipyl work at the molecular level?
Neolipyl's mechanism operates on two connected levels: lipid composition and lipid structure.
Restoring lipid composition. In dry skin, the synthesis of key barrier lipids, particularly ceramides and specific fatty acids, is impaired. Silab's research indicates that Neolipyl's proline-rich peptide fraction stimulates the skin's own lipid synthesis pathways, helping to replenish the depleted lipid pool. This is an endogenous repair approach: rather than depositing exogenous lipids onto the skin surface, as a ceramide-containing moisturizer would, Neolipyl prompts the skin to rebuild its own lipid reserves.
Improving lipid organization. Even when lipids are present in adequate quantities, dry skin can show disordered lamellar structure, where the lipid bilayers that form the barrier are less tightly organized than in healthy skin. Neolipyl also acts on this structural dimension, helping to improve the conformation and organization of the lipid matrix, as supported by Silab's optical biopsy data.
Together, these two actions produce what Silab calls a global repairing effect: addressing the root cause of barrier dysfunction rather than managing its symptoms. The result is a reinforced barrier that loses water more slowly, maintains better hydration, and recovers comfort faster.
The proline-rich peptide fraction is central to this activity. Proline is an amino acid with a distinctive cyclic structure that plays well-documented roles in collagen and extracellular matrix integrity. Its presence in Neolipyl's active fraction likely contributes to the ingredient's influence on structural organization within the lipid matrix, though Silab has not published full mechanistic data in peer-reviewed journals as of mid-2026. The evidence base at this stage is primarily from the company's own clinical and instrumental studies.
What clinical evidence supports Neolipyl's efficacy claims?
Silab's efficacy data for Neolipyl comes from several types of studies, conducted on both Caucasian and Asian volunteers with dry skin.
14-day onset. Twice-daily application of formulas containing Neolipyl produces measurable improvements in microrelief smoothing, skin hydration, and skin comfort within 14 days. This is a relatively fast onset for a barrier-repair active, which typically requires longer timeframes to show structural changes.
Niacinamide-comparable efficacy. Comparative studies have demonstrated what Silab describes as niacinamide-like efficacy for Neolipyl. Niacinamide is one of the most extensively studied skin care actives, with a large independent evidence base for barrier support, hydration, and anti-inflammatory effects. Benchmarking against niacinamide is a meaningful claim, though the comparison is Silab's own and independent replication has not yet been published.
Cross-ethnic validation. Efficacy was demonstrated on both Caucasian and Asian skin types, which is relevant because skin barrier characteristics, including lipid composition and baseline hydration levels, can differ between populations. Validating across both groups strengthens Neolipyl's positioning as broadly applicable rather than optimized for a single skin type.
Instrumental methods. Silab used optical biopsies, non-invasive imaging techniques that allow visualization of skin structure in vivo, in addition to standard hydration measurements. Optical biopsies can reveal changes in lipid lamellar organization that conventional corneometry cannot capture, which adds methodological depth to the evidence.
The evidence is promising but warrants context. All published data comes from Silab's own research program. Independent academic or clinical validation would further strengthen the case, and this is common for newly launched cosmetic actives. The ingredient's recognition by industry peers at two separate Asian trade events suggests the science is regarded as credible within the cosmetics ingredient community.
How does Neolipyl work with retinol, and why does that matter?
One of Neolipyl's more commercially interesting properties is how it behaves when combined with retinol, positioning it not just as a standalone dry-skin active but as a formulation partner for one of the most potent anti-aging ingredients in skincare.
Retinol accelerates cell turnover, stimulates collagen production, and reduces fine lines and wrinkles. It is also well-known for causing a period of adjustment involving dryness, peeling, redness, and discomfort, side effects that lead many users to abandon retinol products before seeing results.
Silab's studies show that when Neolipyl is formulated alongside retinol on normal skin, it limits these adverse effects without altering retinol's anti-wrinkle efficacy. Neolipyl also improves retinol's positive effect on complexion radiance.
This is a real formulation benefit. The persistent challenge with retinol has been the trade-off between efficacy and tolerability. Buffering strategies, such as applying moisturizer before or after retinol or starting at low concentrations, help but add routine complexity. An ingredient that can be co-formulated with retinol to reduce side effects while preserving its benefits addresses a recognized gap.
The likely mechanism relates to Neolipyl's core lipid-repair activity: retinol disrupts the skin barrier as part of its action, and Neolipyl's ability to restore lipid matrix integrity may counteract this disruption at the structural level. This is extrapolation from the available data rather than a published mechanistic conclusion, but it is coherent with what both ingredients are doing.
For formulators, this opens possibilities for retinol products targeting sensitive or dry skin types that have historically been excluded from retinol use, which is a significant segment of the market.
What awards has Neolipyl won, and what do they signal?
Neolipyl received two notable industry recognitions in 2026, both in Asian markets, which are strategically important for premium skincare ingredients.
PCHi Fountain Awards, second prize in the Skin Barrier Repair category. PCHi (Personal Care and Homecare Ingredients) is one of Asia's largest cosmetic ingredient trade shows, held annually in China. The Fountain Awards recognize outstanding innovation in cosmetic ingredients. Neolipyl placed second in the Skin Barrier Repair category on March 18, 2026, behind a solution from Chinese company Shenzhen Dieckmann Biotechnology.
ICIC Award, Science-Technology Innovative Ingredient Benchmark category. On April 21, 2026, Silab won the ICIC Award at the International Cosmetics Innovation Conference in Shanghai. The category title signals recognition for both scientific rigor and the potential to set a standard in its class.
Brigitte Closs-Gonthier noted the back-to-back recognition: "We are very pleased that this efficacy has been recognized, and that, for the second time in just over a month."
Industry awards are not peer-reviewed science, but they carry weight as signals of credibility within the formulator and brand community. Winning in Asia specifically matters because Chinese and broader Asian consumers are among the most informed skincare audiences globally, and China's regulatory scrutiny of cosmetic ingredients is among the strictest in the world. Neolipyl's compliance with Chinese cosmetics regulations, alongside its Asian award track, positions it well for brands targeting those markets.
How is Neolipyl formulated, and what product types can use it?
Neolipyl is available as an aqueous solution, which Silab highlights as making it easy to incorporate into a wide range of product types. Water-soluble actives can be used in formulations that oil-soluble ones cannot, without requiring emulsification or anhydrous systems.
The recommended usage dose is 0.5 to 2%, a relatively low concentration range with favorable cost implications: less active is needed per unit of finished product compared to ingredients used at 5 to 10%.
Silab positions Neolipyl as suitable for any product intended for skin barrier care. In practice, this covers a broad range:
- Moisturizing creams and lotions for dry or very dry skin
- Barrier repair serums
- Sensitive skin formulations
- Retinol-containing products, as a tolerance-supporting co-active
- Post-procedure skincare used after chemical peels, laser treatments, or other procedures that compromise the barrier
- Body care targeting dry skin conditions
The aqueous format also makes Neolipyl compatible with toners, essences, and lightweight fluid formulations, product types that are particularly prominent in Asian skincare routines. This aligns with where the ingredient has gained its first recognition.
How does Neolipyl compare to other barrier-repair ingredients?
The barrier-repair ingredient space has plenty of competition. Ceramides, niacinamide, panthenol, colloidal oatmeal, and various peptides all compete for formulators' attention. Neolipyl's differentiation rests on a few specific points.
Versus ceramide complexes. Topical ceramides work by supplementing the skin's lipid matrix with exogenous ceramides delivered from outside. Neolipyl, by contrast, stimulates the skin's own lipid synthesis, an endogenous approach. Whether this produces superior or merely different outcomes is not yet established by independent comparative data, but the mechanistic distinction is real and meaningful.
Versus niacinamide. Silab's own data benchmarks Neolipyl against niacinamide and claims comparable efficacy. Niacinamide has a much larger independent evidence base built over decades, but it also has known formulation sensitivities, including a reaction with certain vitamin C forms that can produce yellowing. Neolipyl, as a peptide-based aqueous extract, is unlikely to present the same compatibility issues.
Versus peptide complexes. Proline-rich peptides are not new to skincare, but their application specifically to lipid matrix repair, validated by lipidomics, is a novel angle. Most peptide actives in skincare target collagen synthesis or neuromuscular signaling. Neolipyl's lipid-focused mechanism sits in a different space.
Versus retinol sensitization buffers. Ingredients like bakuchiol and various ceramide blends are marketed as retinol companions or gentler alternatives. Neolipyl's co-formulation data with retinol is more specific and more mechanistically grounded than most of these claims, though independent validation remains outstanding.
Neolipyl is a genuinely novel ingredient with a well-defined mechanism and credible early-stage evidence. It is not yet an established workhorse with decades of independent research behind it. Brands and formulators adopting it early are making a judgment call on Silab's science being sound, which is a reasonable position given the company's 40-year track record, but it remains a judgment call.
Who is Silab?
Silab is a French independent biotechnology company founded more than 40 years ago, specializing in the development, manufacture, and marketing of purified, patented natural active ingredients for the cosmetics and dermocosmetics industry. The company supplies major global brands and has built its reputation on science-backed actives with demonstrated efficacy. It is privately held, which gives it more latitude to invest in long-term research programs than publicly traded competitors.
Neolipyl fits into a broader portfolio of targeted skin actives that includes Longevicell (skin longevity), Liftilience (lifting and firming), AD Resyl (atopic dermatitis), and Acnesium (acne-prone skin). The pattern across these is consistent: identify a specific molecular dysfunction in a skin condition, develop a natural active to correct it, and validate efficacy with both instrumental and clinical methods.
The use of lipidomics to characterize dry skin's molecular signature before designing Neolipyl is consistent with this approach and represents a step up in rigor compared to traditional empirical ingredient development.
Is Neolipyl sustainably and ethically sourced?
The cornflower raw material is sourced from French suppliers certified for organic agriculture, a supply chain that is both locally grounded and certified to organic standards. The extraction process uses enzyme engineering, which avoids harsh chemical solvents. The ingredient carries 100% natural origin content per ISO 16128 and complies with biodiversity regulations, an increasingly relevant consideration as the Nagoya Protocol on access and benefit-sharing of genetic resources is enforced more rigorously across cosmetic ingredient supply chains.
For brands building natural or clean positioning, Neolipyl's profile fits well: natural-origin, organically sourced, produced via a clean extraction process, and compliant with the most stringent international regulations.
What to watch for next
Neolipyl launched in 2025 and is still in early market adoption. As of mid-2026 it has two Asian industry awards and is being exhibited at major ingredient trade shows including in-Cosmetics Asia. The next 12 to 24 months will likely determine whether it becomes a widely adopted ingredient or remains a specialist active for barrier-focused formulations.
Independent peer-reviewed studies replicating Silab's efficacy claims would significantly increase confidence in the ingredient's mechanism and outcomes. The cosmetics industry has historically relied heavily on supplier-generated data, but the trend toward greater scientific transparency is accelerating.
Consumer-facing products containing Neolipyl are not yet widely visible in the market as of this writing. As brands begin to launch formulations featuring the ingredient, particularly retinol products with Neolipyl as a tolerance-supporting co-active, real-world consumer feedback will add an important layer of practical evidence.
The retinol co-formulation angle is worth following closely. The global retinol market is large and growing, tolerability is a recognized barrier to adoption, and an ingredient that credibly addresses that barrier while also delivering standalone barrier benefits has a compelling story for formulators.
For consumers with dry or barrier-compromised skin, Neolipyl represents a scientifically grounded option that works through a different mechanism from ceramide supplements or humectants. It is worth looking for on ingredient labels using the INCI name Centaurea Cyanus Flower Extract as more brands incorporate it into their formulations.
Last verified: 2026-05-13
Sources
- Silab leverages cornflower in its new Neolipyl active to address dry skin — Premium Beauty News
- Silab's skin-repairing active ingredient Neolipyl has won another award — Premium Beauty News
- SILAB wins a second award for its active ingredient NEOLIPYL — Euro Cosmetics
- Silab wins ICIC Award for skin-quenching natural active — Happi
- Silab's Neolipyl wins award at the PCHi Fountain Awards — Industries Cosmetiques
- NEOLIPYL product listing — in-Cosmetics Asia
- Silab official website